Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06466057

Metacognitive Therapy for Obsessive-Compulsive Disorder

The Efficacy of Metacognitive Therapy for Obsessive-compulsive Disorder

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
80 (estimated)
Sponsor
Northeast Normal University · Academic / Other
Sex
All
Age
12 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical trial is to learn if metacognitive therapy can be effective in a Chinese sample of obsessive compulsive disorder (OCD) . The main questions it aims to answer are: Can metacognitive therapy significantly reduce participants' levels of obsessive-compulsive symptoms? Can metacognitive therapy significantly improve participants' metacognitive adaptations? The researchers will compare metacognitive therapy to a control condition without psychotherapy to see if metacognitive therapy is effective in treating OCD. Participants will: Receive the metacognitive therapy intervention or under control conditions for 8 to 15 weeks. Be assessed for symptoms and metacognitive beliefs at pre-intervention, post-intervention and 12 weeks post-intervention

Detailed description

This study will be a randomised controlled clinical trial. Participants who meet the enrolment criteria will be randomised into an experimental group and a control group. Participants in the experimental group will receive 8-15 weeks of metacognitive therapy, while participants in the control group will receive the same amount of time of regular treatment without psychotherapy components. The researchers will assess participants' obsessive-compulsive symptoms and metacognitive levels before, after, and 12 weeks after the intervention. Assessment measures will be the Yale Brown Obsessive-Compulsive Scale (Y-BOCS) and the Metacognition Questionnaire (MCQ-30). By comparing the assessment results of the two groups of participants, conclusions will be drawn as to whether metacognitive therapy can have a positive effect on a Chinese OCD sample.

Conditions

Interventions

TypeNameDescription
BEHAVIORALMetacognitive TherapyA one-on-one face-to-face dialogue format will be used to conduct psychotherapy with each participant, and the treatment protocol will be based on the treatment manual for metacognitive therapy.
OTHERGeneral mental health promotionA general mental health mission will be conducted, not covering any metacognitive therapy related content, set for 8-15 weeks, 1 time per week

Timeline

Start date
2024-06-11
Primary completion
2024-09-01
Completion
2024-11-01
First posted
2024-06-20
Last updated
2024-06-20

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06466057. Inclusion in this directory is not an endorsement.